Submitted by Jack Attack on Wed, 05/06/2015 - 12:24pm Please use the scale below to rate your level of confidence as they relate to your knowledge/skill level PRIOR to participating in this activity. * 1=Not at all confident, 5=Extremely confident, N/A=Not applicable for me 12345N/A Your ability to identify asthma symptoms associated with disease progression Your ability to identify asthma symptoms associated with disease progression - 1 Your ability to identify asthma symptoms associated with disease progression - 2 Your ability to identify asthma symptoms associated with disease progression - 3 Your ability to identify asthma symptoms associated with disease progression - 4 Your ability to identify asthma symptoms associated with disease progression - 5 Your ability to identify asthma symptoms associated with disease progression - N/A Your ability to integrate patient communication and education strategies into personalized treatment plans in order to optimize outcomes Your ability to integrate patient communication and education strategies into personalized treatment plans in order to optimize outcomes - 1 Your ability to integrate patient communication and education strategies into personalized treatment plans in order to optimize outcomes - 2 Your ability to integrate patient communication and education strategies into personalized treatment plans in order to optimize outcomes - 3 Your ability to integrate patient communication and education strategies into personalized treatment plans in order to optimize outcomes - 4 Your ability to integrate patient communication and education strategies into personalized treatment plans in order to optimize outcomes - 5 Your ability to integrate patient communication and education strategies into personalized treatment plans in order to optimize outcomes - N/A Many patients with asthma refuse or have been advised not to take aspirin or any other NSAIDS due to aspirin-exacerbated asthma. What percentage of patients has this phenotype of asthma. * <5% 5%-15% 16%-20% 21%-25% A child with severe asthma comes in for an office visit in the summer. The child will be starting a new school year within the next few weeks and you are concerned about the risk of a viral exacerbation. According to a recent study by Dr. Stephen Teach and colleagues, which of the following treatment strategies could prevent hospitalization during this time of increased infection? * Inhaled corticosteroids Omalizumab Omalizumab in addition to inhaled corticosteroids Omalizumab in addition to oral corticosteroids Which of the following statements is true when identifying individuals likely to have steroid-responsive asthma with the measurement of exhaled nitric acid, or FeNO? * A patient is likely to have eosinophilic inflammation in the airways with a high FeNO level, >50 ppb An increased corticosteroid dose will achieve better outcomes in patients with a high FeNO level, >50 ppb A patient is likely to have a greater response from a steroid with a low FeNO level, <25 ppb Both A and B Up to _________ of patients with asthma have increases in neutrophils. * 10% 20% 30% 40% Please use the scale below to rate how often you CURRENTLY use each of the following clinical practice strategies for your patients with asthma? * 1=Never, 2=Not often, 3=Sometimes, 4=Often, 5=Always, N/A=Not applicable for me 12345N/A Utilize appropriate biomarkers when developing personalized treatment plans Utilize appropriate biomarkers when developing personalized treatment plans - 1 Utilize appropriate biomarkers when developing personalized treatment plans - 2 Utilize appropriate biomarkers when developing personalized treatment plans - 3 Utilize appropriate biomarkers when developing personalized treatment plans - 4 Utilize appropriate biomarkers when developing personalized treatment plans - 5 Utilize appropriate biomarkers when developing personalized treatment plans - N/A Apply appropriate biologic therapies in special patient populations Apply appropriate biologic therapies in special patient populations - 1 Apply appropriate biologic therapies in special patient populations - 2 Apply appropriate biologic therapies in special patient populations - 3 Apply appropriate biologic therapies in special patient populations - 4 Apply appropriate biologic therapies in special patient populations - 5 Apply appropriate biologic therapies in special patient populations - N/A Develop a clinician/patient partnership in order to ensure adherence to asthma treatments Develop a clinician/patient partnership in order to ensure adherence to asthma treatments - 1 Develop a clinician/patient partnership in order to ensure adherence to asthma treatments - 2 Develop a clinician/patient partnership in order to ensure adherence to asthma treatments - 3 Develop a clinician/patient partnership in order to ensure adherence to asthma treatments - 4 Develop a clinician/patient partnership in order to ensure adherence to asthma treatments - 5 Develop a clinician/patient partnership in order to ensure adherence to asthma treatments - N/A Leave this field blank
